The largest database of trusted experimental protocols

Cefotaxime

Manufactured by Hardy Diagnostics

Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of bacterial infections. It functions as a broad-spectrum antibiotic effective against a wide range of gram-positive and gram-negative bacteria.

Automatically generated - may contain errors

2 protocols using cefotaxime

1

Isolation and Characterization of Hospital Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
We isolated strain BP-1(T) (bedside rail) and BP-2 (nurse call button) from an intensive care room at a tertiary care hospital in Pakistan with the Eswab collection device and transport system (Becton Dickenson & Company, Franklin Lakes, NJ) in June 2016. Surfaces were swabbed in triplicate during an ongoing yearlong longitudinal sampling study. Swabs were sent to the US at room temperature and arrived in the US within ~3 days of sampling. Samples from Pakistan were received by the Burnham lab under approval of the Washington University IBC Protocol number 6,572. Swabs were cultured within 24 h of arrival in the US laboratory site. The isolates were recovered on MacConkey agar with 5 μg/ml cefotaxime (Hardy Diagnostics, Santa Maria, CA) and re-streaked on blood agar using the four-quadrant method to recover distinct single colonies. The isolates were unidentified by the MALDI-TOF VITEK MS IVD v2.3.3 (bioMerieux, Durham, NC) and Bruker BioTyper (Bruker Daltonics, Billerica, MA) mass spectrometry systems. For subsequent genomic analysis, frozen stocks of each isolate were made by creating a dense suspension of the isolate in Tryptic Soy Broth (Sigma Aldrich, St. Louis, MO) with 15% Glycerol (Hardy Diagnostics, Santa Maria, CA).
+ Open protocol
+ Expand
2

Quantitative Bacterial Enumeration from Environmental Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the samples above, excluding the tap water, were plated on R2A, Middlebrook 7H11 (Remel, Lenexa, KS), Pseudosel (Becton Dickinson, Franklin Lakes, NJ), Chromagar KPC (Chromagar, Paris, France), and MacConkey with 2 mg/L cefotaxime (Hardy Diagnostics, Santa Maria, CA). R2A plates were incubated at 25 °C for 7 days; 7H11 Middlebrook plates were incubated at 30 °C and counted at 3, 5, and 7 days (all samples were CPC treated as described above prior to plating on 7H11 Middlebrook medium); Pseudosel plates were incubated at 35 °C for 24 hrs and then at 25 °C for an additional 24 hrs; Chromagar KPC plates were incubated for 24 hours at 35 °C; and MacConkey with 2 mg/L cefotaxime plates were incubated at 35 °C for 72 hrs. Volume plated was maximum 5 ml (concentrated on a filter), making the limit of detection 6 CFU/ml given a countable plate definition of 30–300 colonies. Final bacterial counts factored in dilutions and the original volume collected or surface area sampled.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!